Trial Profile
HYPOVITAMINOSIS D AND ORGAN DAMAGE IN PATIENTS WITH HYPERTENSION: EFFECTS OF SUPPLEMENTATION WITH CHOLECALCIFEROL
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 17 Apr 2017
Price :
$35
*
At a glance
- Drugs Colecalciferol (Primary)
- Indications Essential hypertension; Vitamin D deficiency
- Focus Therapeutic Use
- Acronyms HYPODD
- 06 Nov 2015 New trial record
- 14 Mar 2015 Planned number of patients changed to 240.